|
1）Morrow AG, Brockenbrough EC. Surgical treatment of idiopathic hypertrophic subaortic stenosis: Technique and hemodynamic results of subaortic ventriculomyotomy. Ann Surg. 1961; 154: 181-9
|
|
|
|
2）Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995; 346: 211-4
|
|
|
|
|
|
3）Spirito P, Seidman CE, McKenna WJ, et al. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997; 336: 775-85
|
|
|
|
|
|
4）Maron B. Hypertrophic cardiomyopathy. Lancet. 1997; 350: 127-33
|
|
|
|
|
|
5）Sherrid MV, Chaudhry FA, Swistel DG. Ob-structive hypertrophic cardiomyopathy: Echocar-diography, pathophysiology, and the continuing evolution of surgery for obstruction. Ann Thorac Surg. 2003; 75: 620-32
|
|
|
|
|
|
6）Maron MS, Olivotto I, Betocchi S, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyo-pathy. N Engl J Med. 2003; 348: 295-303
|
|
|
|
|
|
7）Morrow AG. Hypertrophic subaortic stenosis. Operative methods utilized to relieve left ventricular outflow obstruction. J Thorac Cardiovasc Surg. 1978; 76: 423-30
|
|
|
|
|
|
8）Minakata K, Dearani JA, Nishimura RA, et al. Extended septal myectomy for hypertrophic cardiomyopathy with anomalous mitral papillary muscles or chordae. J Thorac Cardiovasc Surg. 2004; 127: 481-9
|
|
|
|
|
|
9）Sado DM, Flett AS, McGregor CGA, et al. Myectomy plus Alfieri technique for outflow tract obstruction in hypertrophic cardiomyopathy. Circulation. 2010; 122: 938-9
|
|
|
|
|
|
10）Krajcer Z, Leachman RD, Cooley DA, et al. Septal myotomy-myomectomy versus mitral valve replacement in hypertrophic cardiomyo-pathy. Ten-year follow-up in 185 patients. Cir-culation. 1989; 80: I57-64
|
|
|
|
|
|
11）Ommen SR, Maron BJ, Olivotto I, et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005; 46: 470-6
|
|
|
|
|
|
12）Minakata K, Dearani JA, Schaff HV, et al. Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy. Ann Thorac Surg. 2005; 80: 851-6
|
|
|
|
|
|
13）Nagueh S, Groves B, Schwartz L, et al. Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American Registry. J Am Coll Cardiol. 2011; 58: 2322-8
|
|
|
|
|
|
14）Valeti US, Nishimura RA, Holmes DR, et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007; 49: 350-7
|
|
|
|
|
|
15）Agarwal S, Tuzcu E, Desai M, et al. Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010; 55: 823-34
|
|
|
|
|
|
16）Sorajja P, Valeti U, Nishimura RA, et al. Outcome of alcohol ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2008; 118: 131-9
|
|
|
|
|
|
17）Sakata R, Fujii Y, Kuwano H. Thoracic and cardiovascular surgery in Japan during 2009. Gen Thorac Cardiovasc Surg. 2011; 59: 636-67
|
|
|
|
|
18）Maron MS, Olivotto I, Zenovich AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruc-tion. Circulation. 2006; 114: 2232-9
|
|
|
|
|